Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sacubitril 97 mg + Valsartan 103 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10x10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
This tablet is a combination of two medicines that work together to help manage heart failure and improve heart function. Sacubitril helps to relax blood vessels and reduce harmful substances that cause the heart to work harder, while Valsartan blocks a hormone called angiotensin II that tightens blood vessels. Together, they lower blood pressure, reduce the strain on the heart, and help the heart pump blood more efficiently. This medicine is usually prescribed to patients with chronic heart failure to reduce the risk of hospitalization and improve survival.
Common side effects may include low blood pressure, dizziness, cough, high potassium levels, and kidney problems. Rare but serious side effects include swelling of the face or throat (angioedema), severe allergic reactions, or kidney failure. Seek medical attention immediately if you experience severe swelling, difficulty breathing, or sudden swelling.
Used to treat chronic heart failure with reduced ejection fraction and to lower the risk of heart-related complications.
Take this medicine exactly as prescribed by your doctor. Do not stop the medication without consulting your healthcare provider. Regular monitoring of blood pressure, kidney function, and potassium levels is important while on this medication. Inform your doctor if you are pregnant, breastfeeding, have kidney or liver problems, or are taking other medications. Avoid using potassium supplements or salt substitutes unless advised.
Store in a cool, dry place below 30°C, protected from moisture and sunlight. Keep out of reach of children.
Composition : Sacubitril 24 mg + Valsartan 26 mg tablet
Composition : Sacubitril 49 mg + Valsartan 51 mg tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin (5mg) tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Sacubitril 98 mg + Valsartan 102 mg Tablet is an advanced cardiovascular combination therapy used for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). This high-strength combination helps improve heart function, reduce the risk of hospitalization, and lower cardiovascular mortality in heart failure patients. It is widely prescribed by cardiologists and cardiac care specialists, making it a premium product in the cardiovascular and chronic care segment with significant potential in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the growing demand for innovative heart failure therapies. Sacubitril + Valsartan is commonly prescribed as a long-term maintenance treatment, ensuring regular repeat prescriptions, stable sales volumes, and continuous demand from hospitals, cardiac care centers, and retail pharmacies.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiovascular and cardiac care segment, including Sacubitril 98 mg + Valsartan 102 mg Tablet. We provide monopoly rights, quality-assured manufacturing, promotional support, and reliable product supply to help franchise partners establish a strong presence in the growing cardiac care market.
Wholesalers and stockists benefit from strong prescription-based demand, increasing adoption among cardiologists, and long-term patient usage. Since heart failure management requires continuous therapy and follow-up care, this product offers steady product movement, recurring business opportunities, and sustainable profitability in pharmaceutical distribution.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and heart failure management products can contact Cafoli Lifecare to discuss pricing, product availability, monopoly franchise rights, and PCD pharma franchise opportunities. We provide complete support through marketing materials, dependable supply chains, and territory-based business assistance to help partners grow their pharmaceutical business successfully.